Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals

BackgroundPatients with type 2 diabetes mellitus (T2DM) are at increased risk for COVID-19 related morbidity and mortality. Antibody response to COVID-19 vaccine in T2DM patients is not very clear. The present work aims to evaluate the antibody response to the inactivated SARS-CoV-2 vaccine in this...

Full description

Bibliographic Details
Main Authors: Yandong Cheng, Ping Shen, Yue Tao, Wenjun Zhang, Biyun Xu, Yan Bi, Zhen Han, Yi-Hua Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Public Health
Subjects:
T2DM patients
COVID-19
vaccination
inactivated SARS-CoV-2
impaired antibody response
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1025901/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.1025901/full

Similar Items